U.S. Pharmacist



Survey Reveals Poor Insulin Adherence

By Staff 


US Pharm
. 2010;35(10):8. 

Stockholm, Sweden
—According to an international survey, more than one in three patients with diabetes fail to take their insulin as prescribed. The Global Attitudes of Patients and Physicians in Insulin Therapy (GAPP) survey, which was funded by Novo Nordisk, was conducted in eight countries with 2,780 respondents (1,250 physicians and 1,530 patients). It was designed to uncover the challenges patients and physicians are facing in obtaining effective outcomes in insulin therapy. The survey revealed that busy lifestyles, difficulty in adhering to prescribed regimens, and fear of hypoglycemia are key contributing factors to poor glycemic control. It also found that 67% of patients feel that diabetes has controlled their life since starting insulin, while a third of physicians are dissatisfied with the ability of current regimens to fit into patients’ lifestyles.

To comment on this article, contact rdavidson@uspharmacist.com.

U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2016 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.